Oxford Biodynamics PLC (OBD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Oxford Biodynamics PLC (OBD) has a cash flow conversion efficiency ratio of -1.388x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-4.51 Million ≈ $-549.10 USD) by net assets (GBX3.25 Million ≈ $395.67 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see OBD stock market capitalisation for the company's overall valuation and market capitalisation.
Oxford Biodynamics PLC - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Oxford Biodynamics PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Oxford Biodynamics PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oxford Biodynamics PLC ranked by their cash flow conversion efficiency. See OBD debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mercantile Ports & Logistics Ltd
LSE:MPL
|
-0.010x |
|
Image Scan Holdings Plc
LSE:IGE
|
-0.246x |
|
Nanoco Group plc
LSE:NANO
|
-0.051x |
|
Heavitree Brewery
LSE:HVT
|
0.010x |
|
Proteome Sciences PLC
LSE:PRM
|
-0.089x |
|
Tiger Royalties and investments Plc
LSE:TIR
|
-0.272x |
|
Serinus Energy
LSE:SENX
|
0.002x |
|
Seed Innovations Ltd
LSE:SEED
|
-0.032x |
Annual Cash Flow Conversion Efficiency for Oxford Biodynamics PLC (2013–2025)
The table below shows the annual cash flow conversion efficiency of Oxford Biodynamics PLC from 2013 to 2025. View Oxford Biodynamics PLC share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | GBX1.12 Million ≈ $135.78 |
GBX-7.71 Million ≈ $-937.96 |
-6.908x | -195.95% |
| 2024-09-30 | GBX4.36 Million ≈ $530.24 |
GBX-10.17 Million ≈ $-1.24K |
-2.334x | -67.53% |
| 2023-09-30 | GBX6.05 Million ≈ $736.72 |
GBX-8.44 Million ≈ $-1.03K |
-1.393x | +30.35% |
| 2022-09-30 | GBX2.59 Million ≈ $314.88 |
GBX-5.18 Million ≈ $-629.89 |
-2.000x | -126.23% |
| 2021-09-30 | GBX6.69 Million ≈ $814.34 |
GBX-5.92 Million ≈ $-720.05 |
-0.884x | -253.08% |
| 2020-09-30 | GBX13.58 Million ≈ $1.65K |
GBX-3.40 Million ≈ $-413.80 |
-0.250x | -94.01% |
| 2019-09-30 | GBX17.59 Million ≈ $2.14K |
GBX-2.27 Million ≈ $-276.32 |
-0.129x | -33.26% |
| 2018-09-30 | GBX20.05 Million ≈ $2.44K |
GBX-1.94 Million ≈ $-236.29 |
-0.097x | +26.40% |
| 2017-09-30 | GBX11.60 Million ≈ $1.41K |
GBX-1.53 Million ≈ $-185.67 |
-0.132x | +24.40% |
| 2016-09-30 | GBX7.74 Million ≈ $942.10 |
GBX-1.35 Million ≈ $-164.01 |
-0.174x | -28.08% |
| 2015-09-30 | GBX9.04 Million ≈ $1.10K |
GBX-1.23 Million ≈ $-149.53 |
-0.136x | -67.82% |
| 2014-09-30 | GBX5.24 Million ≈ $636.95 |
GBX-424.00K ≈ $-51.59 |
-0.081x | -225.24% |
| 2013-09-30 | GBX2.94 Million ≈ $357.47 |
GBX190.00K ≈ $23.12 |
0.065x | -- |
About Oxford Biodynamics PLC
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor i… Read more